We previously described the presence of advanced oxidation protein products (AOPP), a novel marker of oxidative stress in the plasma of hemodialyzed patients (HD). The present study was carried out to further investigate how myeloperoxidase (MPO)-catalyzed reactions could contribute to AOPP generation in the plasma. First, patterns of plasma protein oxidation obtained after in vitro incubation of control plasma with hypochlorous acid (HOCl) were compared to those from HD patients and control plasma. The use of various analytical techniques enabled localising and identifying the main oxidized proteins with albumin (HSA) after protein separation by size-exclusion chromatography and SDS-PAGE electrophoresis. The characterization of the oxidation level of the individual plasma proteins in terms of carbonyl groups and 3-nitrotyrosine formations was performed by immunoblotting. Secondly, to highlight the significance of AOPP index monitored by spectrophotometry, spectra were established for plasma fractions from HD patients and compared to data for control plasma and HOCltreated plasma. The corresponding absorbance difference spectra were matched with external standards such as dityrosine, nitrotyrosine and pentosidine and elaborated chromophoric probe models. Indeed, HSA was chlorinated by HOCl reagent or HOCl generated via the MPO/ H 2 O 2 /Cl À system and was nitrated by tetranitromethane. Increased absorbances at the range of 340 nm were observed both with chlorinated and nitrated HSA. Finally, our results indicate that HOCl, and not NO 2 S , generated via MPO activity, could represent one of the pathways for AOPP production in plasma proteins exposed to activated phagocytes. D
Introduction
The characterization of the specific oxidants responsible for the modification of biomolecules in disease processes has been challenging. Biomarkers of reactive oxygen species reactions have the potential not only to determine the extent of oxidative injury, but also to predict the potential efficiency of therapeutic strategies aimed at reducing such an oxidative stress. Activated phagocytes are a major source of reactive oxidants and play a fundamental role in host defense [1, 2] . They contain the heme enzyme myeloperoxidase (MPO) which catalyzes the reaction of chloride ion with hydrogen peroxide (H 2 O 2 ) to generate large amounts of hypochlorous acid (HOCl), a powerful oxidizing and chlorinating agent produced by neutrophils [3, 4] . Several recent studies demonstrate that MPO also utilizes H 2 O 2 and nitrite (NO 2 À ), the metabolic end product of NO, as substrates to generate a microbicidal oxidant capable of nitrating phenolic compounds and proteins in vitro [5 -8] . Indeed, both oxidative products react with a wide range of oxidizable biomolecules and have been invoked as causing tissue damage in a wide variety of unrelated pathologies [1, 2, 9] . In particular, it has been shown that HOCl-modified proteins are present in atherosclerotic lesions [10, 11] and glomerular nephritis [12, 13] .
Oxidative stress has long been incriminated in the development of the dialysis-related pathology. To estimate the degree of oxidant-mediated protein damage in the plasma of uremic patients, i.e. patients with chronic renal failure and patients in maintenance dialysis therapy (HD), the presence of advanced oxidation protein products (AOPP) was investigated. We showed that in vivo plasma levels of AOPP closely correlate with levels of dityrosine, a hallmark of oxidized proteins and with pentosidine, a marker of protein glycation closely related to oxidative stress [14, 15] . A new chromogen was found which caused increased absorbance at 340 nm and its spectrophotometric determination was proposed as a novel index of oxidative stress measuring the level of AOPP [14] . Levels of AOPP highly correlated with the creatinine clearance, thus revealing that AOPP were excellent markers of the progression of chronic renal failure [14] . Interestingly, the significant correlation between AOPP and neopterin, a marker of macrophage activation, demonstrated that AOPP were closely linked to phagocyte activation. In addition, in vitro, HOCl-treated HSA and in vivo-generated AOPP were able to trigger oxidative bursts in neutrophils as well as in monocytes, thereby appearing to act as true inflammatory mediators [16, 17] . Regarding the AOPP generation mechanism, in vitro studies pointed out that HOCl-treated HSA was capable of triggering an oxidative burst [15] .
The purpose of the present work was: (i) to provide new data on the biochemical and molecular characteristics of AOPP using a fast, reproductive and high performance separation of plasma proteins; (ii) to document the mechanisms leading to the formation of AOPP within plasma specially focusing on MPO activities with chloride and nitrite ions; (iii) to establish the contribution of the potential chromophores in the spectrophotometric determination of AOPP. The use of various analytical techniques enabled localising and identifying the main oxidized proteins with HSA. To interpret the spectral modifications detected in HD plasma fractions, we described in detail some structural modifications that occur as a result of plasma or HSA treatment with HOCl. Our results indicate that NO 2 S generated by MPO activity is not implicated in AOPP production, whereas HOCl may represent one of the pathways for AOPP production in plasma proteins exposed to activated phagocytes.
Materials and methods

Chemicals and reagents
Human serum albumin was purchased from CalbiochemNovabiochem Corp. Hydrogen peroxide, potassium iodide, chloramine T and sodium hypochlorite were obtained from Sigma Chemical Co. (St. Louis, MO, USA). Hydrogen peroxide stock solutions were prepared by appropriate dilutions of 30% H 2 O 2 in deionized water. Their concentrations were determined spectrophotometrically (e 240 =43.6 M À1 cm À1 ) [18] and the required dilutions were made on a daily basis. New solutions of HOCl/OCl À (pK a =7.6) [19] were prepared by diluting commercial NaOCl in 10 mM NaOH before use. In this report, the term HOCl will refer to the sum of both species. The hypochlorite concentration was determined spectrophotometrically at 292 nm (e=350 M À1 cm À1 ) after dilution with 10 mM NaOH [19] . All other chemicals used were of the highest grade available and were prepared daily in distilled deionized water. All experiments were performed in 50 mM phosphate pH 7.4.
Blood collection and plasma isolation
In HD patients, blood was drawn from the fistula needle just before the start of a hemodialysis session. In control patients, venous blood (5 -10 ml) was collected in standard sterile polystyrene vacuum tubes, with 5 mM EDTA. Following centrifugation (600Âg for 10 min) the plasma was stored in 500 Al aliquots at À70 jC until use. Assays were carried out on duplicate samples, which had been thawed once.
Determination of AOPP equivalents
AOPP were determined in the plasma or in the fractions using the semi-automated method previously devised in our laboratory [14] . Briefly, AOPP are measured by spectrophotometry on a microplate reader (Model MR 5000, Dynatech, Paris, France), and are calibrated with chloramine T solutions (Sigma) which in the presence of potassium iodide absorb at 340 nm, thus defining an AOPP index [20] .
Spectrophotometric analyses of AOPP
Absorbance spectra and repetitive scans were performed using a Kontron Uvicon 930 spectrometer interfaced with a computer making it possible to collect, manipulate and analyze the data with the corresponding appropriate software. Absorbance spectra were recorded from 500 to 200 nm at 240 nm/min and 1 nm/point in a 1 cm light-path cuvette. Plasma fractions of HD patients and controls were recorded after a convenient dilution in 50 mM phosphate buffer pH 7.4 to obtain a maximum absorbance level at 280 nm below 1.2. Absorbance difference spectra between control and HD plasma solutions or between control HSA and oxidized HSA, normalized to the same absorbance at 280 nm, were calculated and plotted using the Kaleidagraph V.3.08 program. As the absorbance difference corresponded to the added contribution of several chromophores, the experimental data were fit to spectra of known chromophores (tyrosine derivatives, pentosidine) and adjusted to the desired height, i.e. passing through the experimental data points.
Modification of HSA and control plasma with reagent HOCl
The HSA (Calbiochem) concentration was measured by absorbance at 280 nm (e=35 mM À1 cm À1 ) [21] . A 15 AM HSA solution (1 mg/ml of protein) was incubated for 30 min with various HOCl concentrations from 0.3 to 4 mM at 37 jC. The oxidation reaction was stopped using 1 mM methionine and HSA was separated on a PD-10 Sephadex column (Amersham Pharmacia). Plasma at the protein concentration of 60 mg/ml was incubated with increasing HOCl concentrations in the range of 4 -100 mM. An appropriate dialysis allows the removal of non-reactive HOCl. Then the HOCl-treated plasma was fractioned by molecular sieving.
MPO characteristics
MPO was purified from human polymorphonuclear neutrophils by sequential heparin-agarose affinity and anionexchange chromatographies as previously described in Ref. [22] . The enzyme preparation used in this study exhibited a purity index (A 428 /A 279 ) equal to or higher than 0.81. The MPO concentration, expressed as haem concentration, was determined spectrophotometrically (e 430 =89 mM À1 cm À1 ) [23] .
Oxidative treatment of HSA
When HSA was oxidized by the MPO system, to 15 AM HSA (1 mg/ml) in a 50 mM phosphate buffer pH 7.4 and 100 mM NaCl, 12 additions of 80 AM H 2 O 2 were made at 10-min intervals at 37 jC to ensure complete conversion to HOCl. MPO 20 nM was added at the start and subsequently at every second addition of H 2 O 2 . After the final addition of H 2 O 2 , the sample was left for 1 h to ensure that all the HOCl had reacted before the oxidation reaction was stopped by using 1 mM methionine. Then MPO-treated HSA was separated on a PD-10 Sephadex column (Amersham Pharmacia).
Preparation of nitrated HSA
HSA nitration was performed by tetranitromethane (TNM) treatment according to Ref. [24] . Briefly, HSA in 50 mM phosphate buffer pH 7.4 was treated (1 h, 37 jC) with TNM at a 300 molar ratio (TNM/HSA). Unreacted TNM and nitroformate were removed by exhaustive dialysis. Then, nitrated HSA (nitro-HSA) was separated on a PD-10 Sephadex column (Amersham Pharmacia). The 3-nitrotyrosine content was determined spectrophotometrically using e 430 =4.2 mM À1 cm À1 [25] after making the solution alkaline with 2N NaOH. In the two nitro-HSA samples prepared, the extent of nitration was 6 and 12 mol nitrotyrosine/mol protein (or 30% and 65%), respectively.
Plasma fractioning
To achieve separations of AOPP bound to the plasma proteins, a gel filtration was performed on a Superose 12 HR 10/30 column adapted to a FPLC system (Amersham Pharmacia). Aliquots of 0.5 ml of plasma 5-fold diluted in 50 mM phosphate buffer pH 7.4 were injected on to the column equilibrated with the same buffer and eluted at a flow rate of 0.3 ml/min. Detection was performed at 280 nm. To calibrate the column, the molecular protein standards of Amersham Pharmacia containing blue dextran 2000 (2000 kDa), thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa), albumin (67 kDa), ovalbumin (45 kDa), chymotrypsinogen A (25 kDa) and ribonuclease A (13.7 kDa) were used. After 30 runs, the 1 ml collected fractions gathered for identical elution volume were pooled and concentrated 10 times by ultrafiltration on Centricon Plus-20, PL-10 (Amicon). The resulting fractions were kept frozen or used for spectral analyses and assayed as detailed below.
Protein determination
Protein concentration was determined using the dyebinding method of Bradford [26] with Coomassie Blue G-250. A commercially available kit (Bio-Rad, Richmond, CA, USA) was used with bovine serum albumin as a standard.
Molecular mass determination
Fractions containing AOPP activity were examined by SDS-PAGE under denaturing and reducing conditions [27] using a 12% polyacrylamide slab gel (13Â90Â1.5 mm). Samples of fractions and molecular mass standards were diluted in Laemmli buffer and heated for 10 min at 95 jC. Gels were developed with Coomassie blue procedures. Colored molecular mass standards (Sigma) were used for calibration.
Measurement of amino acid changes
Dityrosine measurement
Protein solutions were analyzed for the presence of dityrosine by fluorescent measurements using a Kontron SF 25 spectrophotometer. Aliquots of plasma fractions were added to solutions of 20 mM phosphate buffer pH 7.5 in the presence of 7 M urea [28] . After a 30-min incubation time, the fluorescent emission spectra of dityrosine was recorded from 550 to 350 nm following excitation at 320 nm. Dityrosine has a characteristic emission spectrum with a maximum at 410 nm. The assay was calibrated with authentic dityrosine prepared using the HRP-catalyzed oxidation of tyrosine by H 2 O 2 [29] described in Ref. [15] and quantified using the extinction coefficient e 315 =4.5 mM À1 cm À1 at pH 7.5.
Amino acid analysis
The amino acids composition of oxidized HSA was established by M. Courteau at the Sequence Laboratory of the Institut de Biologie et Chimie des Protéines (CNRS, Lyon, France). The samples were introduced in a reactor containing a mixture of HCl 6N/TFA/thioglycolic acid (2V/ 1V/5%) under a nitrogen flux. Acid hydrolysis of peptidic bonds was carried out for 45 min at 150 jC in a Water Pico Tag station. Samples were then dried under vacuum and diluted in a Beckman buffer. Then, the amino acids were separated on an ion exchange column and eluted with a gradient of buffers, which differed in their ionic strength, pH values and temperature. After elution, the amino acids were revealed with ninhydrine at 135 jC and monitored at 570 nm, or at 440 nm for proline derivatives. Finally, the data were analysed with Gold software.
Carbonyl content and nitrotyrosine formation by immunoblots
These detections implied SDS-PAGE using 10% polyacrylamide gels and Western blotting. HOCl-treated HSA, nitrated HSA and fractions of plasma protein samples were run in a Bio-Rad miniprotean chamber as above. Proteins were transferred to nitrocellulose membranes blocked in 2% nonfat dry milk in PBS buffer. Carbonyl groups were detected on oxidized proteins using OxyBlot Protein Oxidation Kit (Intergen, Purchase, NY, USA). Proteins were derivatized for 15 min with 2,4 dinitrophenylhydrazine (DNP) in SDS and electrophoresed according to Laemmli. After immunoblotting, a rabbit anti-DNP antibody (Intergen) (dilution 1:1000) enabled the detection of carbonyl groups derivatized with DNP. The binding antibody was detected with a goat anti-rabbit IgG conjugated with HRP (Amersham, UK) (dilution 1:2000). Bands were visualized with chemo-luminescent chemicals and captured on films at various exposure times. Detection of tyrosine nitration was performed with an affinity-purified rabbit polyclonal IgG antibody raised against peroxynitrite-treated LKH (keyhole limpet haemocyanin) (Calbiochem, Darmstadt, Germany) (dilution 1:1000). The binding antibody was detected using a goat anti-rabbit IgG secondary antibody conjugated with HRP (dilution 1:2000) and visualized by enhanced chemiluminescence. An in vitro nitrated sample of HSA was analyzed at the same time. The colored molecular mass standards (Sigma): a-lactalbumin (15 kDa), soybean trypsin inhibitor (29 kDa), carbonic anhydrase (33 kDa), ovalbumin (45 kDa), albumin (74 kDa), h-galactosidase (145 kDa) and myosin (240 kDa) were used for calibration. Electrophoresis results then presented were representative of experiments performed three times.
Results
Chromatographic properties of plasma proteins
To compare the molecular species present in control plasma and in plasma from HD patients, a molecular sieving Fig. 1 . Typical elution profiles of plasma proteins. Top panels: from left to right, typical elution profile of plasma proteins from (A) control plasma, (B) HD patient, and (C) control plasma incubated with 10 mM HOCl. Plasma was loaded on a Superose 12 equilibrated in 50 mM phosphate pH 7.4. The elution flow rate was 0.3 ml/min. Bottom panels: fractions of 1 ml were collected to determine elution volume and analyzed spectrophotometrically at 280 nm (solid circles) and 340 nm (squares), respectively, for (D) control plasma, (E) HD patient and (F) control plasma incubated with 10 mM HOCl. Calibration of the column in molecular masses was indicated together with the corresponding fractions. Fractionation was performed on eight HD plasma and compared with eight controls and five HOCl-treated plasma.
of the plasma was performed by size-exclusion chromatography on a Superose 12 column in line with a FPLC system which achieved a fast, reproductive and automatic recycling for these routine preparative purposes (Fig. 1, upper panels) . When elution volumes were compared with those of standard proteins, three major peaks were detected at 670, 170 and 71 kDa in the plasma of both control (Fig. 1A) and HD patients (Fig. 1B) in fractions 8, 12 and 13 , respectively, thus, confirming our previous data obtained with a lowpressure system [14] . Furthermore, in the present study, a quantitative analysis of the peak area showed that the peak at 670 kDa was twice as high in HD than in control plasma, indicating a significant aggregation of the proteins in HD patients. This observation has been confirmed by comparing the peak area, which had a ratio of 0.5, 0.5, 1, respectively in HD plasma versus 0.25, 0.5, 1 in the control plasma. To provide some insights into the in vivo formation mechanisms of oxidized proteins in HD plasma catalyzed by the activity of MPO, the molecular masses distribution of control plasma incubated with increasing HOCl concentrations were established by FPLC (Fig. 1C) . Typically, oxidatively modified plasma by 10 mM HOCl showed a FPLC gel-filtration profile closely resembling that of HD patients with peak areas at 670, 170, and 71 kDa in a ratio of 0.7, 0.6, and 1, respectively.
For each fraction, the absorbance spectrum was recorded and protein concentration and AOPP content, expressed by absorbance at 280 and 340 nm, respectively, were determined (Fig. 1, lower panels) . The AOPP detection followed the protein peaks in the plasma from HD, with a high level collected in fraction 13 at 71 kDa, representing mainly native HSA (Fig. 1E) . In contrast, no obvious peaks of AOPP could be detected in any fraction of control plasma (Fig. 1D) . Spectrophotometric determinations underlined that the mobility and size of the native proteins were altered by HOCl oxidation as showed by the increase in high molecular weight proteins (fractions 8 -11) associated with high AOPP levels as in HD patients (Fig. 1F) . As expected, a linear correlation (R 2 =0.93) was obtained between the maximum absorbance determined at 280 nm and the protein concentration measured by colorimetric reaction. Moreover, for HD plasma fractions, a linear correlation was still obtained between A 340 determined on the spectrophotometer and the AOPP index (R 2 =0.91) (data not shown), thus, suggesting a direct and valuable verification of the presence of AOPP by spectrophotometry using a 1 cm light-path cuvette. This set of data demonstrated the reliability of the microtiter plate reader in the clinical evaluation of plasma AOPP as first described by us [14] and confirmed by others [30 -32] .
SDS-PAGE analyses of protein fractions
SDS-PAGE analysis was performed to describe the polypeptide components of the elution pattern of control plasma and HD plasma. Under denaturing and reducing conditions, protein aggregates became dissociated and soluble as shown in high-molecular mass proteins fractions 8 -10 from control plasma ( Fig. 2A) . In contrast, fraction 8 from HD, associated with a high AOPP level, showed a diffused smear, corresponding to high molecular mass covalent aggregates which were stable to reduction and which expanded over 98 -240 kDa, presumably as a result of cross-linking (Fig. 2B) . The major differences in the patterns were found in fractions numbered 11 -14, which contained AOPP in HD fractions. In control plasma fractions, a single band at around 67 kDa, which corresponds to albumin, was detected. In contrast, HD fractions 11 -14 revealed the presence of a larger band of g globulin heavy chain at 52 kDa associated with albumin at 67 kDa. An additional band at 80 kDa (a-h globulin) could be detected together with a dimeric form of albumin at 116 kDa in HD fractions 12, 13 and 14 and not in corresponding control fractions. In conclusion, the comparison of the patterns observed in HD fractions and control fractions underlines that plasma AOPP result from the association of several oxidized proteins, including HSA and gamma globulins.
After exposure to HOCl (Fig. 2C) , protein aggregation or cross-linking was clearly evident by the presence of a smear in the high molecular range in fractions 8 -10. Interestingly, one single band at 67 kDa was detected in fractions 12 -14 with a significant increase in protein staining in fractions 13 and 14. These data showed that AOPP, generated in vivo and detected in HD fractions, have polypeptide components different from those induced in HOCl-treated plasma, thus, suggesting that the in vivo mechanisms of AOPP generation include but are not restricted to the HOCl action.
Evaluation of oxidation extent
Dityrosine formation
Previously, we showed that dityrosine production was a useful marker for the presence of protein oxidation in HD plasma [14] . A close correlation between AOPP (Amol/l) and dityrosine levels (nmol/mg protein) in HOCl-treated HSA have been reported. In the present study, the correlation was confirmed between dityrosine levels determined by fluorescence measurements, and AOPP levels measured by absorbance at 340 nm in fractions 12-14 of several HD patients (data not shown). Dityrosine contents determined in these HD fraction were scattered from 0.4 to 1.1 nmol of dityrosine per mg protein with absorbance at 340 nm in the range of 0.03 -0.2. When a standard curve was established with HOCl-treated HSA samples of known dityrosine content, the mean value at 0.7 nmol DT/mg protein for HD fraction would correspond to the effect of a 30-min incubation time with HOCl at a relatively low molar ratio, i.e. 35 HOCl/HSA molar ratio. 
Determination of protein carbonyl content
The extent of carbonyl-modified proteins was assessed by a Western blot immunoassay performed on FPLC plasma fractions. In control plasma, no significant band was revealed using anti-DNP detection in any fraction (Fig.  3A) . In contrast, HD fraction 11-12-13-14 displayed protein bands of molecular masses centered on 67 kDa with an intense anti-DNP signal (Fig. 3B) , indicating increased carbonyl content. However, less carbonyl staining was found in association with fraction 8, although it was associated with a high AOPP level. These results confirmed the presence of a high level of oxidized proteins in HD plasma as compared to controls. Exposure of plasma to 10 mM HOCl (Fig. 3C ) generated a significant increase in anti-DNP signals from protein of molecular masses 67 and 52 kDa, regardless of the fraction considered. These data underlined that carbonyl-modified proteins are restricted to specific HD fractions containing AOPP levels, whereas HOCl treatment of plasma led to carbonyl formation widespread over the whole pattern. Thus, these data enabled to conclude that anti-DNP detection is a likely approach to reveal differences between in vivo AOPP and those generated by HOCl treatment.
Determination of nitrotyrosine in plasma fractions
Western blot analysis of nitrotyrosine was first standardized using HSA submitted to TNM treatment to generate nitrotyrosine as described in Materials and methods. Fig. 4A demonstrates that the antibody anti-nitrotyrosine reacts with HSA-nitrotyrosine and that this reactivity is dependent on the dose of TNM used for nitrotyrosine synthesis and thus on the amount of nitrotyrosine generated on HSA. However, HSA and HOCl-treated HSA did not react with the nitro- tyrosine antibody (Fig. 4A) . Interestingly, Western blot analyses of the whole pattern of plasma fractions revealed that nitrotyrosine-associated proteins could be detected in fractions 13-15, at the level of 67 kDa, both in controls and HD plasma (Fig. 4B,C) . These data showed that AOPP was not related to nitrotyrosine formation.
Amino acid analysis
In order to specify which other amino acids could be implicated in reactions with 10 mM HOCl, a complete analysis of the HSA amino acid composition was carried out and the results are presented in Table 1 . We first verified that the values obtained for a native HSA of 585 amino acids were in line with the sequence and amino acid composition obtained from GenBank (access number A06977). Data showed that an exposure to HOCl induced a change in the content of some specific amino acids: positively charged amino acids lysine and histidine, tyrosine and methionine. This composition confirmed the loss of tyrosine residues, suggested by the loss of fluorescent emission at 350 nm after excitation at 280 nm [15] , and the expected modification of the methionine residue, known to be one of the amino acids which reacts the most rapidly with HOCl [33, 34] . It was observed that 3-chlorotyrosine, a possible product of the reaction of tyrosine chlorination by HOCl, eluted at the same retention time as histidine and therefore could not be quantified. Aliphatic amino acids and hydroxy amino acids were not significantly modified. All these results demonstrate that the presence of HOCl results in a selective modification of some specific protein amino acids.
Spectral properties of in vitro model systems
Since plasma proteins were found nitrated by Western blotting, spectra of nitrated-HSA were first investigated. At pH 7.4, two peaks at 436 and 361 nm were detected as compared to native HSA. They disappeared with reduction by dithionite, which reduces nitrotyrosine to colorless aminotyrosine. With an increase in pH, the maximum absorbance shifted from 360 to 430 nm, characteristic of the presence of nitrotyrosine [24, 25] (data not shown).
Since chlorinated oxidants appeared to be the most efficient for inducing AOPP in HSA [15] , we further studied spectral characteristics of HOCl-induced AOPP in control plasma fractions and HSA, compared to those of untreated plasma fractions and native HSA. As shown in Fig. 5 (lines a and b), the peak difference between native and modified HSA solutions obtained by incubation with HOCl or with the MPO/H 2 O 2 /Cl À system occurred at 310 nm and appeared to be the feature of HSA treated with chlorinated oxidants. Interestingly, a similar absorbance difference spectrum is observed in fraction 13 of plasma treated with HOCl (Fig. 5, line c) .
Spectral properties of HD plasma protein fractions
Absorbance spectra in the range 500 -200 nm were recorded on fractions eluted from FPLC and containing high levels of AOPP. Spectral analyses of the absorbance spectra of HD fraction 13, eluting at the albumin position and containing AOPP, showed that the absorbance was significantly increased between 300 and 450 nm compared with normal plasma fractions (Fig. 6A) . To quantify these differences, absorbance difference spectra between HD fractions and corresponding fractions in control plasma were established. As shown in Fig. 6B , the peak difference occurred at approximately 310 nm and, to a lesser extent, at 340 nm, thus underlining the spectral contribution of several chromophores associated with AOPP. Of note, these spectral changes were not modified on acidification or alcalinisation and in the presence of dithionite.
The absorbance difference spectra established for HD plasma fraction 13 were globally corrected for the contribution of AOPP generated by HOCl by subtraction of the data obtained for HOCl-treated plasma in the corresponding fraction (Fig. 5, line c) . The results are presented in Fig. 7 for different HD patients and show that the absorbance intensity detected at 340 nm is correlated to the AOPP content. In the search of a potential candidate chromophore to account for the resulting absorbance band at 340 nm pentosidine has been put forward. Previously, we showed that the levels of AGE-pentosidine and AOPP were correlated in plasma from HD patients [15] . We therefore suggested that AGE-pentosidine and AOPP may share common structural and/or spectrophotometric features. Interestingly, the spectrum of pentosidine has a band centered Fig. 7 . Spectral changes associated with AOPP in HD plasma fractions. Spectra obtained when corrections were made for the contribution of AOPP generated by HOCl treatment of control plasma. Difference spectra of HOCl-treated plasma (Fig. 5, line c) was subtracted from difference spectra of HD fractions with different AOPP content (HD1, HD2, HD3 and HD4) (Fig. 6B) after normalization to the same height at 310 nm. The spectrum of a 40 AM pentosidine solution (crosses), with maximal absorbance at 337 nm, fitted the HD4 data.
at 337 nm which matches the spectral data of the HD fraction (Fig. 7) . Therefore, the absorbance of pentosidine may contribute to AOPP measurements.
Discussion
The present study was aimed at providing new advances in the molecular species and spectral properties of AOPP present in high levels in plasma of HD patients. Our data show that AOPP are MPO-mediated oxidized HSA. Elution patterns obtained after plasma fractioning by a novel and reproductive FPLC of HD plasma provided a correlation between two peaks of AOPP and two distinct molecular species centered at 670 and 71 kDa. Parallel SDS-PAGE showed that HSA and globulins matched the low molecular mass AOPP peak, while the high molecular mass AOPP peak is mostly due to aggregates of HSA likely resulting from disulfide bridges and/or dityrosine cross-linking. Thiol groups of HSA are known to account for the major antioxidant capacity of normal human plasma [35, 36] . Indeed, data from the HSA protein model studied in the present work showed a decrease in methionine residues upon HOCl treatment, which is known to react as equally as cysteine [33, 34, 37] . Thus, evidence of aggregation was likely to be attributed to new intermolecular covalent bonds. This is consistent with the dityrosine detection, which can account for subunit cross-linking and higher molecular mass complexes on reducing gels [28,38 -41] .
An elution pattern similar to AOPP peaks was obtained after treatment of normal plasma by HOCl. In fractions 12, 13, and 14 associated with AOPP, a single band of HSA was found associated with protein carbonyls, thus, confirming that HSA was the major target for HOCl oxidation. In contrast, differences in the whole pattern were noticed in the molecular composition and carbonyl distribution in HD and HOCl-treated plasma fractions. Taken together, these results provide strong proof that AOPP correspond to highly oxidized proteins and specifically to HSA, however, the in vivo mechanisms of AOPP generation is not restricted to a HOCl reaction.
Interestingly, when purified HSA was used as a model protein to investigate the modifications in plasma proteins by chlorinated oxidants, the HOCl treatment mediated attacks on lysine residues known to form chloramine [42] . In our previous studies on HD plasma, chloramines were not detected [14] . Presently, protein carbonyl groups were detected in plasma fractions, thus in agreement with published reports [43, 44] showing that chloramines are slowly hydrolyzed into aldehydes, thus increasing the pool of detected carbonyl groups.
Of interest, plasma protein carbonyl formation could be induced by peroxynitrite and nitrating agents generated through MPO activity [5, 9] . The presence of 3-nitrotyrosine is a selective marker of nitration in biological fluids [45] . In the present study, we did not observe a significant difference in nitrotyrosine distribution in HD plasma fractions 12-14 compared to normal plasma fractions, as detected by Western blotting. This finding made it possible to conclude a relatively greater involvement of the MPO/H 2 O 2 /Cl À system compared to that of MPO/H 2 O 2 /nitrite in forming AOPP in HD plasma proteins in vivo. This conclusion was supported by spectrophotometric investigations of plasma fractions which demonstrated the absence of effect due to pH variations and addition of dithionite on the spectral changes detected in HD plasma fractions 12 -14 and in fractions from HOCl-treated plasma, compared to those of nitrated HSA.
We previously reported that AOPP can be quantified by absorbance measurements at 340 nm, thus defining a novel marker of oxidative damage [14] . To further investigate the significance of these absorbance changes, spectrophotometric studies on plasma fractions first underlined, the overlapping of two chromophoric bands with maxima at 310 and 340 nm detected in the difference absorbance spectra of HD plasma fractions. Secondly, content modifications or characteristics of chromophores were induced by chlorinated oxidants. A decrease in tyrosine residues was noticed upon HOCl treatment of HSA. These results agree with published reports on chlorination reactions in proteins involving the formations of 3-chlorotyrosine [46, 47] , 3,5-dichlorotyrosine [48] and dityrosine [39] , which all are known to absorb in a range of 280 -320 nm in the phenoxide state. Indeed, HOClmodified proteins were detected in early and acute stages of inflammation, e.g. glomerular defects [13, 49] . Finally, data support the conclusion that the chromophore at 310 nm could be related to the presence of modified tyrosines induced by the activity of MPO in the presence of H 2 O 2 and chloride.
An interesting finding in the present study is that, when the AOPP spectral contribution generated by HOCl was taken into account, the corresponding spectrum revealed an absorbance maximum at 340 nm matching the spectrum of pentosidine. In a previous study [15] , the close correlation observed between plasma AGE-pentosidine and AOPP suggested that AGE and AOPP may share a common formation mechanism and/or common biological activities in vivo. Indeed, published reports pointed out the involvement of oxidative pathways in the formation of AGE in patients with end-stage renal failure [50, 51] . Finally, AOPP are mainly associated with oxidized HSA and dependent on MPO chlorination activities, but not exclusively, since their quantitation also involve detecting pentosidine, a molecule which results from crosslinks in proteins between arginine and lysine via oxidized glucose.
Our final goal was to validate the AOPP determination as a sensitive, accurate and surrogate marker for MPO-derived oxidative stress which could be useful in clinical applications. In this report, we demonstrated that the method for AOPP measurement using a microtiter plate reader, which we have previously devised in our laboratory, is as reliable as the method based on a conventional spectrophotometer with a 1 cm light-path cuvette. Therefore, AOPP could be determined routinely using a simple protocol to investigate MPO-induced oxidative stress. It should be noted that several other groups have successfully determined AOPP and considered AOPP as a potential useful marker for clinical purposes. The relevance of AOPP in chronic renal failure has been confirmed by several groups [17,32,52 -54] . We and others, have demonstrated the importance of AOPP in coronary artery disease [31, 55] . AOPP have also been investigated in the field of diabetes [56] , preterm neonates [57] and dendritic cell stimulation [30] .
In conclusion, the present work showed: (i) that AOPP result from MPO-derived oxidative stress, but not exclusively; (ii) that the spectral characteristics of AOPP correspond to several chromophores which include dityrosine, carbonyls and pentosidine but not nitrotyrosine; (iii) that AOPP could be routinely measured using our previously devised method for clinical investigations.
